相关实验视频
Updated: Jun 24, 2025
07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
19.4K
凯瑟利西丁-HG通过抑制GPVI介导的血小板激活来缓解败血症诱导的血小板功能障碍
Weichen Xiong1, Jinwei Chai1, Jiena Wu1
1NMPA Key Laboratory for Research and Evaluation of Drug Metabolism, Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou 510515, China.
Research (Washington, D.C.)
|June 6, 2024
概括
一种新的Cathelicidin,Cath-HG,通过向葡萄糖蛋白VI (GPVI) 来抑制血小板激活,有效地治疗败血症. 这种可以减少器官损伤,并改善败血症小鼠的存活率,为新的抗血栓治疗提供了潜力.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 血小板激活在败血症中至关重要,导致微血栓,炎症和器官功能障碍.
- 凯瑟利西丁在败血症调节中的作用尚不清楚.
- 来自Hylarana guentheri (Cath-HG) 的cathelicidin是一种具有潜在治疗应用的新.
研究的目的:
- 为了研究Cath-HG的结构和功能.
- 评估Cath-HG在体内和体外对败血症和相关并发症的治疗效果.
- 为了确定Cath-HG在血小板调节中的分子标.
主要方法:
- 使用核磁共振光谱学进行Cath-HG结构确定.
- 在小鼠体内败血症模型 (血栓绑定和刺穿) 和血栓形成模型 (FeCl3诱导的动脉损伤).
- 关于血小板聚合,葡萄糖蛋白VI (GPVI) 信号,点抹,ELISA和拉下测试的体外研究.
- 分子对接和位点定向突变发生,以确定关键的Cath-HG残留物.
主要成果:
- Cath-HG具有α螺旋结构,通过减少器官损伤和炎症,提高了败血症小鼠的生存率.
- 甲基HG可以缓解败血症诱导的血栓缺血和微血栓症.
- 通过准GPVI信号通路,Cath-HG特别抑制原诱导的血小板聚合.
结论:
- Cath-HG是一种新的Cathelicidin,具有显著的抗败血症和抗血栓性质.
- GPVI是Cath-HG的关键标,表明其作为治疗性药物的潜力,用于与败血症相关的血栓塞缩和血栓事件.
- Cath-HG为开发针对GPVI介导的血小板激活的新型抗血小板疗法提供了基础.
相关概念视频
01:22Formation of the Platelet Plug
5.8K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.8K
01:09GPCRs Regulate Adenylyl Cylase Activity
5.5K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
519
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
519